- Home
- PMVP vs GNTA Comparison
PMVP vs GNTA Comparison
Compare PMVP & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.24
HOLD
Current Price
$1.45
Company Overview
Basic Information| Metric | PMVP | GNTA |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 34.0M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PMVP | GNTA |
|---|---|---|
| Price | $1.24 | $1.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 278.2K | 94.9K |
| Earning Date | 11-12-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $1.28 |
| 52 Week High | $1.84 | $10.00 |
Technical Indicators
Market Signals| Indicator | PMVP | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 36.36 |
| Support Level | $1.20 | $1.28 |
| Resistance Level | $1.28 | $1.68 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 55.00 | 22.78 |
Price Performance
Historical Comparison PMVP
GNTA
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.